Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ · Healthcare
Madrigal Pharmaceuticals, Inc. Long Term Debt 2012–2025
Madrigal Pharmaceuticals, Inc. annual long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Madrigal Pharmaceuticals, Inc. long term debt as of December 31, 2025: 339.9M, a 189.09% increase year-over-year.
- Madrigal Pharmaceuticals, Inc. long term debt for 2025 were 339.9M, a 189.09% increase from 2024.
- Madrigal Pharmaceuticals, Inc. long term debt for 2024 were 117.6M, a 1.81% increase from 2023.
- Madrigal Pharmaceuticals, Inc. long term debt for 2023 were 115.5M, a 65.74% increase from 2022.
- Madrigal Pharmaceuticals, Inc. long term debt for 2022 were 69.7M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Madrigal Pharmaceuticals, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $340 |
| 2024 | $118 |
| 2023 | $115 |
| 2022 | $70 |
Madrigal Pharmaceuticals, Inc. Long Term Debt — FAQ
Madrigal Pharmaceuticals, Inc. (MDGL) long term debt over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MDGL's long term debt history?
The chart and table above show Madrigal Pharmaceuticals, Inc.'s long term debt by year and by quarter, including the growth rate.